MedTech Innovator

Samay is a developer of an innovative AI-enabled wearable device focused on remote respiratory health management. The company addresses the growing need for effective chronic obstructive pulmonary disease (COPD) diagnostics and management, projected to incur significant healthcare costs in the coming years. Their patented chest patches provide passive monitoring of lung function, achieving 90% accuracy in COPD diagnosis and 83% accuracy in detecting exacerbation biomarkers. The device continuously tracks vital respiratory metrics, including pulmonary volumes, heart rates, and breathing sounds for two weeks, offering users valuable insights to optimize their respiratory health. Additionally, Samay is creating an AI-assisted management platform that supports patients and healthcare providers throughout the care continuum, enhancing personalized care from the comfort of home.

FibriCheck is a medically certified application designed for the screening and monitoring of irregular heart rhythms, including atrial fibrillation. Functioning as a software-only solution, it allows users to measure their cardiac rhythm simply by placing a finger on their smartphone camera, making it accessible for use anytime and anywhere. The application automatically shares the collected data with medical professionals, facilitating quicker diagnoses and the development of appropriate treatment plans. Additionally, FibriCheck employs an artificial intelligence platform that is device-agnostic, enabling it to leverage everyday smartphones and wearables. This innovative approach aims to enhance cardiovascular care by accurately detecting and tracking heart rhythm issues, while also helping individuals manage conditions such as high blood pressure and heart failure through user-friendly tools and customizable health plans.

Invicta Medical, Inc. is a medical technology company that specializes in developing innovative therapies for sleep apnea and snoring. Founded in 2013 and headquartered in Portola Valley, California, the company has created a wearable device that utilizes neurostimulation to detect and treat disturbed breathing. This device aims to overcome the limitations of traditional therapies, which are often costly, invasive, and have low compliance rates among patients. By offering a smart, comfortable, and cost-effective solution, Invicta Medical seeks to provide effective treatment options for individuals suffering from sleep disorders.

SmartCardia SA is a Swiss company, established in 2013 and based in Lausanne, that specializes in the design and development of cardiac monitoring devices and cloud-based AI software. The company focuses on real-time patient monitoring by integrating advanced medical wearable technology with artificial intelligence. SmartCardia has created SmartNeuralNet, a cutting-edge machine learning technology that enhances their medical wearables. These ultra-small devices are designed to continuously track vital bio-signals, including heart rate, breathing rate, and skin conductance, allowing patients to monitor their health effectively. Through a dedicated mobile application, SmartCardia aims to provide actionable insights to individuals with chronic conditions, ultimately empowering them to improve their overall health management.

Samay is a developer of an innovative AI-enabled wearable device focused on remote respiratory health management. The company addresses the growing need for effective chronic obstructive pulmonary disease (COPD) diagnostics and management, projected to incur significant healthcare costs in the coming years. Their patented chest patches provide passive monitoring of lung function, achieving 90% accuracy in COPD diagnosis and 83% accuracy in detecting exacerbation biomarkers. The device continuously tracks vital respiratory metrics, including pulmonary volumes, heart rates, and breathing sounds for two weeks, offering users valuable insights to optimize their respiratory health. Additionally, Samay is creating an AI-assisted management platform that supports patients and healthcare providers throughout the care continuum, enhancing personalized care from the comfort of home.

DiaMonTech AG is a Berlin-based medical technology company founded in 2015, specializing in the design, development, and commercialization of non-invasive blood glucose monitoring devices. Utilizing proprietary laser-based photo-thermal detection technology, DiaMonTech offers solutions that allow diabetes patients to measure their glucose levels without the pain of finger pricking or the need for blood samples. The company has developed several innovative products, including D-BASE, a shoebox-sized device for conducting human trials, D-pocket, a portable device for frequent glucose level tracking, and D-BAND, a wearable device that continuously monitors blood glucose levels. Through these advancements, DiaMonTech aims to improve the quality of life for individuals managing diabetes.

NanoBioFAB is a company based in Frederick, Maryland, specializing in the development of wearable, smart healthcare and medical devices utilizing nanotechnology. Founded in 2015, the company produces innovative products such as iNose, a device that allows individuals to detect, track, and monitor their body’s skin vapor-print. This device connects wirelessly to mobile phones, enabling users to track their fat burning rate, assess the effectiveness of their exercise routines, and observe the long-term effects of their dietary choices on metabolic rates. Additionally, NanoBioFAB offers nanoprinting technology and artificial intelligence sensors aimed at enhancing telemedicine and personalized healthcare solutions. The company is dedicated to making advanced healthcare accessible and affordable for both people and pets.

Neurava is a healthcare company focused on improving the lives of epilepsy patients through the development of non-invasive wearable diagnostic devices. These devices monitor critical biological signals associated with epilepsy and the risk of sudden unexpected death in epilepsy (SUDEP), offering a reliable solution for both patients and their caregivers. By providing accurate and timely alerts, especially during nighttime, Neurava's technology empowers caregivers to respond quickly and take preventive actions, thereby enhancing patient safety and peace of mind. The company's commitment to advancing medical device manufacturing and health diagnostics highlights its role in addressing the challenges faced by those with uncontrolled epilepsy.

Proton Intelligence, founded in 2020 and headquartered in Vancouver, Canada, specializes in biomarker monitoring to manage chronic diseases and enhance patient outcomes. The company focuses on continuous potassium monitoring, particularly for patients suffering from hyperkalemia associated with chronic kidney disease and other co-morbidities. Proton Intelligence's innovative platform provides accurate and real-time potassium measurements through interstitial fluid analysis, which correlates closely with blood levels. This capability is critical for enabling timely and informed decision-making regarding patient care, allowing clinicians and patients to effectively manage medications, dietary choices, and treatment options. By prioritizing precise monitoring, Proton Intelligence aims to significantly improve the health and lives of individuals affected by hyperkalemia.

CardieX Limited is a global health technology company specializing in cardiovascular health management. Founded in 1994 and headquartered in Sydney, Australia, the company designs, manufactures, and markets medical devices aimed at measuring patient risk for hypertension, cardiovascular disease, and other vascular disorders. Its product offerings include devices that utilize patented SphygmoCor technology to assess arterial stiffness and central blood pressure waveforms. Additionally, CardieX develops the Arty platform, which provides physiological and health analytics for wearable devices. The company also offers TeleHealth Services, connecting patients with health coaches through digital and mobile tools. CardieX's solutions are provided to hospitals, clinics, research institutions, and pharmaceutical companies globally. The company has strategic partnerships, including a collaboration with Blumio Inc. for developing wearable sensors and a joint development agreement with inHealth for hypertension and cardiovascular programs. CardieX was previously known as AtCor Medical Holdings Limited until its name change in June 2018.

Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

Senseye, Inc. is a Los Angeles-based company founded in 2015 that specializes in developing innovative smart contact lenses capable of non-invasively recording and analyzing information from users. These contact lenses are designed to infer human emotions, thoughts, and health states, thereby assisting in various applications such as market research, disease diagnosis, and early detection of medical conditions like strokes and heart attacks. By utilizing novel measurements of ocular physiology, Senseye aims to quantify cognitive abilities and psychological well-being, providing valuable insights into vital signs, attention, cognitive load, and fatigue. The company is committed to advancing technology that enhances emotional responses and mental health diagnostics, enabling clinicians to offer personalized care and effectively track patient outcomes over time.

JuneBrain, LLC is a biotechnology company focused on enhancing the management of multiple sclerosis through innovative technology. Founded in 2017 and headquartered in Washington, D.C., the company is developing a wearable, non-invasive imaging device that allows patients to monitor their disease activity from the comfort of their homes. This device is designed to facilitate the early detection of multiple sclerosis attacks and improve the monitoring of treatment efficacy. By leveraging telemedicine, JuneBrain aims to optimize remote assessments of neurological conditions, with the long-term objective of expanding its technology to address a wider range of neurodegenerative diseases. The company's approach is intended to enable more frequent and accessible monitoring of brain health, thereby enhancing patient care.

Neurava is a healthcare company focused on improving the lives of epilepsy patients through the development of non-invasive wearable diagnostic devices. These devices monitor critical biological signals associated with epilepsy and the risk of sudden unexpected death in epilepsy (SUDEP), offering a reliable solution for both patients and their caregivers. By providing accurate and timely alerts, especially during nighttime, Neurava's technology empowers caregivers to respond quickly and take preventive actions, thereby enhancing patient safety and peace of mind. The company's commitment to advancing medical device manufacturing and health diagnostics highlights its role in addressing the challenges faced by those with uncontrolled epilepsy.

CARI Health is a digital health company based in San Diego, California, that specializes in developing remote medication monitors. Founded in 2015 and incorporated in 2021, CARI Health's innovative monitors utilize wireless sensors worn on the patient's skin to continuously transmit real-time data about medication levels to the cloud. This technology enables clinicians to safely prescribe, dose, and monitor adherence to life-saving medications, thereby enhancing patient care and treatment outcomes.

LiveMetric is a medical device company focused on developing innovative, non-invasive sensing and deep data analytics solutions aimed at improving the management of hypertension and cardiovascular diseases. The company offers a wearable, cuff-free device for blood pressure monitoring that is FDA-cleared and validated for accuracy against traditional arterial line methods. This technology provides high-fidelity arterial pressure waveforms and continuous tracking of vital signs, allowing for real-time feedback and analysis for patients, physicians, and healthcare providers. By delivering personalized data and detailed activity mapping, LiveMetric aims to empower individuals, payors, self-insured employers, and healthcare providers, ultimately enhancing the care and quality of life for over one billion people worldwide affected by these conditions.

MindMics is an innovative company specializing in wearable technology that enhances personal health monitoring through sound-based platforms. By integrating advanced sound technology into earbuds and hearing aids, MindMics accurately measures vital health metrics, including heartbeat, circadian rhythms, breathing, and body temperature. This real-time data collection allows users to gain meaningful insights into their bodily functions, ultimately promoting improved well-being and mental performance. By providing accessible health monitoring solutions, MindMics aims to empower individuals to enhance their focus, satisfaction, and overall mental peace.

CardiaCare is a developer of a wearable medical device aimed at the non-invasive treatment and monitoring of atrial fibrillation (AFib) in patients. The company's innovative device employs a closed-loop approach combined with machine learning algorithms to deliver personalized peripheral neuromodulation. This technology mediates a cardiovascular antiarrhythmic response, enabling users to effectively reduce the burden of atrial fibrillation and its precursors, such as premature atrial contractions. As a result, CardiaCare’s solution offers users rapid clinical and symptomatic relief, providing a valuable tool for managing their condition in a home setting.

Augment Health is a company focused on developing noninvasive medical devices and artificial intelligence algorithms to enhance the management of bladder dysfunction, particularly for the 7 million patients affected by neurologic disease or injury. The company's innovative technology allows for monitoring urine levels through a device that can be attached to catheters, providing timely notifications to users or care providers when the catheter reaches capacity. This approach aims to shift bladder diagnostics from clinical settings to patients' homes, addressing the high rate of inconclusive test results associated with traditional in-clinic diagnostics. By enabling better bladder health management, Augment Health seeks to prevent complications such as bladder muscle atrophy, ultimately improving the quality of life for patients.

Flosonics Medical is a Canadian medical device company founded in 2017, specializing in the development of non-invasive sensors aimed at enhancing the management of critically ill patients. Its flagship product, the FloPatch, is a wearable ultrasound sensor designed to monitor blood flow in patients post-clinical intervention, thereby addressing critical clinical needs. The FloPatch is particularly beneficial for healthcare professionals, including physicians, nurses, and paramedics, operating in various high-pressure environments such as ambulances, emergency departments, operating rooms, and intensive care units. The device is notable for its portability, wireless connectivity with tablets and other medical equipment, and user-friendly functionality, all of which contribute to improved patient care in urgent medical situations. Flosonics Medical, previously known as Ke2 Technologies, rebranded in September 2017.

Sepsis Scout is a developer of a wearable patch designed to predict the onset of sepsis in high-risk patients in home care settings. Utilizing proprietary deep learning technology, the device aims to detect sepsis more accurately than current standards of care. By enabling patients to manage chronic illnesses effectively, Sepsis Scout's solution helps individuals stay out of the hospital and alleviates the fear and uncertainty associated with serious health conditions. The company's focus on artificial intelligence and wearables positions it at the forefront of innovative healthcare solutions.

Evergaze, Inc. is a company based in Richardson, Texas, that specializes in developing innovative visual aids for patients suffering from macular degeneration. Founded in 2016, the company has created a prescription eyewear device featuring a monocular electronic vision augmentation system, which is integrated into one lens to enhance visual capabilities. The founding team comprises highly experienced engineers with a proven track record in managing technical projects from conception to production. Drawing from their extensive backgrounds in commercial, industrial, and defense sectors, the team has focused on fulfilling a humanistic mission by leveraging their expertise to produce the seeBoost® device. This product is the result of comprehensive consultations with stakeholders in the low vision community, including patients, healthcare practitioners, and researchers, ensuring it meets the needs of its users effectively.

toSense, Inc. is a healthcare technology company based in San Diego, California, focused on developing innovative solutions for at-home monitoring of chronic illnesses. Incorporated in 2008 and previously known as Perminova, Inc., the company specializes in the CoVa Monitoring System, a body-worn sensor designed for patients with conditions such as congestive heart failure and chronic obstructive pulmonary disease. This device, resembling a necklace, measures vital signs including thoracic impedance, heart rate, and respiration rate, using disposable electrodes to ensure accurate monitoring. The collected data is transmitted via gateways to a web-based system, allowing healthcare professionals to review patient information and detect potential health issues earlier than traditional methods. toSense emphasizes the integration of its hardware and software solutions to address real-world medical challenges effectively. As of March 31, 2020, toSense operates as a subsidiary of Baxter International Inc.

Respirix, Inc. is a United States-based company focused on developing advanced analysis sensors for monitoring breath exhalation and cardiogenic oscillations. The company offers digital health software and hardware designed to provide proprietary insights into the pulmonary vasculature in a non-invasive manner. Respirix's product pipeline targets both at-home monitoring and critical care applications, specifically in areas such as heart failure and hemodynamics. Its innovative approach aims to enhance patient care by delivering precise and actionable data related to respiratory and cardiovascular health.

Koya Medical, Inc. is a healthcare company based in Oakland, California, founded in 2018. The company specializes in developing innovative wearable therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. Koya Medical's technology offers active compression therapy that enhances mobility and personalized care, addressing limitations commonly associated with traditional compression methods. Its sensor-based closed-loop system provides patient-specific patterned compression, enabling healthcare providers to effectively manage conditions like chronic edema and chronic venous insufficiency. Through its breakthrough treatments, Koya Medical seeks to transform the standard of care for individuals affected by these debilitating conditions.

Spire Health, established in 2013 and headquartered in San Francisco, specializes in developing health-tracking devices and remote patient monitoring solutions. The company's core product is a wearable device that senses physical movement, position, and breathing patterns, providing insights into daily activities and mental state through a mobile application. Spire Health focuses on chronic respiratory disease management, offering solutions for conditions such as COPD, congestive heart failure, asthma, and sleep disorders. Their mission is to empower patients and physicians with useful, actionable data by harnessing the power of algorithms and sensors, thereby improving health outcomes.

Palmm is a medical device company that specializes in providing innovative solutions for excessive sweating, also known as hyperhidrosis. The company has developed a convenient at-home treatment that targets specific areas of the body, such as the hands, by applying a mild electrical current through wearable garments. This process effectively deactivates sweat glands for extended periods, offering a safe and non-invasive alternative for individuals seeking relief from profuse sweating. By addressing this common issue, Palmm aims to help customers regain confidence and improve their quality of life, allowing them to avoid the social discomfort often associated with excessive sweating.

Nanowear, Inc. is a technology company specializing in textile-based nanosensor solutions for wireless and real-time electrophysiological monitoring. Founded in 2014 and headquartered in Brooklyn, New York, with a research and development facility in University Park, Pennsylvania, Nanowear develops innovative products such as SimplECG, a remote cardiac monitoring undergarment, and SimpleSense, designed for the management of congestive heart failure. These garments collect multi-channel electrocardiogram (ECG), heart rate, and respiratory rate data, transmitting it to a web-based portal accessible by healthcare professionals via a mobile application. The company's proprietary technology serves various markets, including cardiac, neurological, industrial safety, government, sports medicine, and performance diagnostics, providing accurate, continuous, and cost-effective diagnostic data in an unobtrusive manner.

Tueo Health is dedicated to improving asthma management, particularly for children. The company has developed an innovative solution that combines accurate, objective indicators of asthma control with clinical insights tailored to the needs of patients and their families. This system includes a contactless sensor designed to monitor and manage asthma effectively, allowing users to track treatment progress and outcomes. By focusing on these aspects, Tueo Health aims to enhance the quality of life for those living with asthma.

Spry Health, based in Palo Alto, California, develops digital health solutions aimed at improving care for chronically ill patients. The company offers a clinical-grade wearable device and a disease management platform that provides real-time analytics to healthcare payers. This technology helps manage patient conditions remotely, avoid preventable hospitalizations, and reduce overall healthcare spending by focusing on the small percentage of patients who account for a significant portion of health costs. Spry Health's solutions enhance timely care delivery through individualized analytics, ultimately improving patient outcomes and decreasing hospitalization rates. The company was incorporated in 2013.

MiNDERA Corporation specializes in the development of non-invasive molecular testing devices aimed at diagnosing skin cancer and other skin diseases. The company has created a micro-needle array patch that allows for pain-free and minimally invasive extraction of biomarkers, such as RNA, DNA, and proteins, from the skin without the need for traditional biopsies. Additionally, MiNDERA develops specialized patches for whole transcriptome extraction and skin microbiome extraction, which are designed for research applications. Founded in 2013, MiNDERA is headquartered in Palo Alto, California.

UnaliWear Inc. is a Texas-based company founded in 2013 that creates advanced wearable technology designed to enhance the independence and safety of seniors. Its flagship product, the Kanega watch, is often likened to an "OnStar for People," offering discreet support for falls, medication reminders, and guidance for those at risk of wandering. The watch features a user-friendly speech interface, eliminating the need for buttons, and incorporates a patented battery system, allowing continuous use without the necessity for recharging. Built with integrated cellular, Wi-Fi, GPS, and Bluetooth technologies, the Kanega watch provides round-the-clock medical alerts and utilizes artificial intelligence to learn and adapt to the wearer’s lifestyle. This innovative approach aims to empower vulnerable seniors by ensuring they receive timely assistance while maintaining their dignity and independence.

TinyKicks is a technology company headquartered in Irvine, California, founded in 2014 by France Helfer. The company specializes in developing a wireless smart sensor system that captures fetal movement using machine learning to promote healthy pregnancy outcomes. Its flagship product, the TinyKicks eMotion fetal activity monitor, is a wearable device that detects the user's baby kicks, distinguishing them from the mother's movements. This continuous monitoring provides real-time data, which is automatically uploaded to the user's smartphone. The system utilizes machine learning algorithms to identify abnormal fetal movement, enabling pregnant women to receive timely notifications about potential complications, thereby reducing costs associated with pregnancy-related issues and enhancing overall pregnancy health tracking.